The Safety Profile of Amiodarone Among Older Adults (Age ≥75 Years): A Pharmacovigilance Study from the FDA Data
Authors:
- 20 January 2025
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 138 (5) , 819-826
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Amiodarone: A Comprehensive Guide for CliniciansAmerican Journal of Cardiovascular Drugs, 2020
- Meta-Analysis Comparing the Relative Risk of Adverse Events for Amiodarone Versus PlaceboThe American Journal of Cardiology, 2019
- Clinical Outcomes of Rate vs Rhythm Control for Atrial Fibrillation in Older People: A Systematic Review and Meta-AnalysisDrugs & Aging, 2019
- Atrial Fibrillation in the ElderlyDrugs & Aging, 2013
- Population-Level Incidence and Risk Factors for Pulmonary Toxicity Associated With AmiodaroneThe American Journal of Cardiology, 2011
- Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect?Clinical Research in Cardiology, 2010
- Frequency, Characteristics, and Risk Factors for Amiodarone NeurotoxicityArchives of Neurology, 2009
- Thyroid Function Abnormalities during Amiodarone Therapy for Persistent Atrial FibrillationThe American Journal of Medicine, 2007
- Histopathologic analysis of suspected amiodarone hepatotoxicityHuman Pathology, 1990
- Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patientsHepatology, 1989